Botox has been used off-label for this indication, but the FDA approval should help with reimbursement. Botox was FDA-approved for upper-limb spasticity in 2010 (#msg-47616915).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.